{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T19:27:35Z","timestamp":1774121255738,"version":"3.50.1"},"reference-count":65,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Chest Medicine"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1016\/j.ccm.2012.02.001","type":"journal-article","created":{"date-parts":[[2012,3,30]],"date-time":"2012-03-30T22:32:04Z","timestamp":1333146724000},"page":"371-380","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["The Use of Antiinflammatory Therapy and Macrolides in Bronchiectasis"],"prefix":"10.1016","volume":"33","author":[{"given":"Charles","family":"Feldman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ccm.2012.02.001_bib1","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.prrv.2010.10.011","article-title":"Pathogenesis of bronchiectasis","volume":"12","author":"King","year":"2011","journal-title":"Paediatr Respir Rev"},{"key":"10.1016\/j.ccm.2012.02.001_bib2","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1136\/adc.2007.130054","article-title":"Non-cystic fibrosis bronchiectasis: its diagnosis and management","volume":"95","author":"Stafler","year":"2010","journal-title":"Arch Dis Child Educ Pract Ed"},{"key":"10.1016\/j.ccm.2012.02.001_bib3","series-title":"Respiratory infections","first-page":"347","article-title":"Bronchiectasis","author":"Wilson","year":"2001"},{"key":"10.1016\/j.ccm.2012.02.001_bib4","series-title":"Respiratory medicine","first-page":"1286","article-title":"Bronchiectasis","author":"Cole","year":"1995"},{"key":"10.1016\/j.ccm.2012.02.001_bib5","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1111\/j.1440-1843.2009.01569.x","article-title":"Clinical challenges in managing bronchiectasis","volume":"14","author":"Tsang","year":"2009","journal-title":"Respirology"},{"issue":"6","key":"10.1016\/j.ccm.2012.02.001_bib6","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1164\/ajrccm.151.6.7767536","article-title":"Elevated levels of exhaled nitric oxide in bronchiectasis","volume":"151","author":"Kharitonov","year":"1995","journal-title":"Am J Respir Crit Care Med"},{"issue":"10","key":"10.1016\/j.ccm.2012.02.001_bib7","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1136\/thx.53.10.867","article-title":"Increased levels of exhaled carbon monoxide in bronchiectasis: a new marker of oxidative stress","volume":"53","author":"Horvath","year":"1998","journal-title":"Thorax"},{"issue":"3","key":"10.1016\/j.ccm.2012.02.001_bib8","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1164\/ajrccm.158.3.9710031","article-title":"Elevated levels of expired breath hydrogen peroxide in bronchiectasis","volume":"158","author":"Loukides","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"issue":"8","key":"10.1016\/j.ccm.2012.02.001_bib9","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1136\/thx.53.8.685","article-title":"Increases in CD4+ T lymphocytes, macrophages, neutrophils and interleukin 8 positive cells in the airways of patients with bronchiectasis","volume":"53","author":"Gaga","year":"1998","journal-title":"Thorax"},{"issue":"7","key":"10.1016\/j.ccm.2012.02.001_bib10","doi-asserted-by":"crossref","first-page":"965","DOI":"10.2165\/00003495-200767070-00002","article-title":"Is there a role for inhaled corticosteroids and macrolide therapy in bronchiectasis?","volume":"67","author":"King","year":"2007","journal-title":"Drugs"},{"issue":"18","key":"10.1016\/j.ccm.2012.02.001_bib11","doi-asserted-by":"crossref","first-page":"3183","DOI":"10.1517\/14656566.8.18.3183","article-title":"Pharmacotherapy for bronchiectasis","volume":"8","author":"Loebinger","year":"2007","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.ccm.2012.02.001_bib12","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1378\/chest.08-0776","article-title":"Bronchiectasis","volume":"134","author":"O\u2019Donnell","year":"2008","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.ccm.2012.02.001_bib13","first-page":"20","article-title":"Bronchiectasis, part 2: management","volume":"29","author":"Prasad","year":"2008","journal-title":"J\u00a0Respir Dis"},{"key":"10.1016\/j.ccm.2012.02.001_bib14","first-page":"1507","article-title":"Bronchiectasis","volume":"2008","author":"ten Hacken","year":"2008","journal-title":"Clin Evid (Online)"},{"issue":"4","key":"10.1016\/j.ccm.2012.02.001_bib15","doi-asserted-by":"crossref","first-page":"407","DOI":"10.2165\/00003495-200969040-00002","article-title":"Pharmacological treatment options for bronchiectasis. Focus on antimicrobial and anti-inflammatory agents","volume":"69","author":"Ilowite","year":"2009","journal-title":"Drugs"},{"key":"10.1016\/j.ccm.2012.02.001_bib16","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/j.1752-699X.2009.00131.x","article-title":"Bronchiectasis: an update","volume":"3","author":"Pappalettera","year":"2009","journal-title":"Clin Respir J"},{"key":"10.1016\/j.ccm.2012.02.001_bib17","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1136\/pgmj.2009.091041","article-title":"Non-cystic fibrosis bronchiectasis: diagnosis and management in 21st century","volume":"86","author":"Goeminne","year":"2010","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.ccm.2012.02.001_bib18","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1177\/1753465810366858","article-title":"New treatment options for bronchiectasis","volume":"4","author":"Metersky","year":"2010","journal-title":"Ther Adv Respir Dis"},{"key":"10.1016\/j.ccm.2012.02.001_bib19","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.prrv.2010.10.012","article-title":"Update on treatment of childhood bronchiectasis unrelated to cystic-fibrosis","volume":"12","author":"Redding","year":"2011","journal-title":"Paediatr Respir Rev"},{"issue":"3","key":"10.1016\/j.ccm.2012.02.001_bib20","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2165\/11588150-000000000-00000","article-title":"Targeting airway inflammation in cystic fibrosis in children: past, present, and future","volume":"13","author":"Pressler","year":"2011","journal-title":"Paediatr Drugs"},{"key":"10.1016\/j.ccm.2012.02.001_bib21","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.prrv.2011.01.001","article-title":"Bronchiectasis: so much yet to learn and to do","volume":"12","author":"Chang","year":"2011","journal-title":"Paediatr Respir Rev"},{"key":"10.1016\/j.ccm.2012.02.001_bib22","doi-asserted-by":"crossref","first-page":"i1","DOI":"10.1136\/thx.2010.136119","article-title":"British Thoracic Society Bronchiectasis (non-CF) Guideline Group: a sub-group of the British Thoracic Society Standards of Care Committee. British Thoracic Society Guideline for non-CF bronchiectasis","volume":"65","author":"Pasteur","year":"2010","journal-title":"Thorax"},{"key":"10.1016\/j.ccm.2012.02.001_bib23","article-title":"Non-cystic fibrosis bronchiectasis","author":"Subie","year":"2010","journal-title":"J\u00a0Paediatr Child Health"},{"issue":"2","key":"10.1016\/j.ccm.2012.02.001_bib24","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0954-6111(06)80227-1","article-title":"Inhaled steroids in patients with bronchiectasis","volume":"86","author":"Elborn","year":"1992","journal-title":"Respir Med"},{"issue":"3","key":"10.1016\/j.ccm.2012.02.001_bib25","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1164\/ajrccm.158.3.9710090","article-title":"Inhaled fluticasone reduces sputum inflammatory indices in severe bronchiectasis","volume":"158","author":"Tsang","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"10.1016\/j.ccm.2012.02.001_bib26","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1136\/thx.2002.003236","article-title":"Inhaled fluticasone in bronchiectasis: a 12 month study","volume":"60","author":"Tsang","year":"2005","journal-title":"Thorax"},{"issue":"1","key":"10.1016\/j.ccm.2012.02.001_bib27","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1046\/j.1440-1843.2002.00360.x","article-title":"Regression of bilateral bronchiectasis with inhaled steroid therapy","volume":"7","author":"Tsang","year":"2002","journal-title":"Respirology"},{"key":"10.1016\/j.ccm.2012.02.001_bib28","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1016\/j.rmed.2005.12.002","article-title":"Inhaled steroids improve quality of life in patients with steady-state bronchiectasis","volume":"100","author":"Martinez-Garcia","year":"2006","journal-title":"Respir Med"},{"issue":"6","key":"10.1016\/j.ccm.2012.02.001_bib29","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1111\/j.1365-2710.2008.00951.x","article-title":"Withdrawal of inhaled steroids in children with non-cystic fibrosis bronchiectasis","volume":"33","author":"Guran","year":"2008","journal-title":"J\u00a0Clin Pharm Ther"},{"key":"10.1016\/j.ccm.2012.02.001_bib30","article-title":"Inhaled steroids for bronchiectasis","volume":"1","author":"Kapur","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"10.1016\/j.ccm.2012.02.001_bib31","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1183\/09031936.00016908","article-title":"Adrenal suppression in bronchiectasis and the impact of inhaled corticosteroids","volume":"32","author":"Holme","year":"2008","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ccm.2012.02.001_bib32","article-title":"Oral steroids for bronchiectasis (stable and acute exacerbations)","volume":"4","author":"Lasserson","year":"2001","journal-title":"Cochrane Database Syst Rev"},{"issue":"7","key":"10.1016\/j.ccm.2012.02.001_bib33","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1002\/ppul.21211","article-title":"Resolution of extensive severe bronchiectasis in an infant","volume":"45","author":"Crowley","year":"2010","journal-title":"Pediatr Pulmonol"},{"issue":"6","key":"10.1016\/j.ccm.2012.02.001_bib34","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1002\/ppul.1076","article-title":"Anti-inflammatory effects of macrolides in lung disease","volume":"31","author":"Jaffe","year":"2001","journal-title":"Pediatr Pulmonol"},{"issue":"6","key":"10.1016\/j.ccm.2012.02.001_bib35","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1055\/s-2004-815669","article-title":"Macrolides as biological response modifiers in cystic fibrosis and bronchiectasis","volume":"24","author":"Bush","year":"2003","journal-title":"Semin Respir Crit Care Med"},{"key":"10.1016\/j.ccm.2012.02.001_bib36","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ijantimicag.2007.08.001","article-title":"Macrolides beyond the\u00a0conventional antimicrobials: a class of potent immunomodulators","volume":"31","author":"Giamarellos-Bourboulis","year":"2008","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ccm.2012.02.001_bib37","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1183\/09031936.00042208","article-title":"Long-term macrolide therapy in chronic inflammatory airway diseases","volume":"33","author":"Crosbie","year":"2009","journal-title":"Eur Respir J"},{"issue":"5","key":"10.1016\/j.ccm.2012.02.001_bib38","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1378\/chest.10-0196","article-title":"Chronic macrolide therapy in inflammatory airways diseases","volume":"138","author":"Friedlander","year":"2010","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.ccm.2012.02.001_bib39","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1159\/000320320","article-title":"Immunomodulatory effects of macrolide antibiotics\u2014part 2: advantages and disadvantages of long-term, low-dose macrolide therapy","volume":"81","author":"Altenburg","year":"2011","journal-title":"Respiration"},{"issue":"280","key":"10.1016\/j.ccm.2012.02.001_bib40","first-page":"308","volume":"7","author":"Bochet","year":"2011","journal-title":"Rev Med Suisse"},{"issue":"9","key":"10.1016\/j.ccm.2012.02.001_bib41","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1183\/09031936.99.13236199","article-title":"A\u00a0pilot study of low-dose erythromycin in bronchiectasis","volume":"13","author":"Tsang","year":"1999","journal-title":"Eur Respir J"},{"issue":"6","key":"10.1016\/j.ccm.2012.02.001_bib42","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/j.rmed.2011.01.009","article-title":"Long-term, low-dose erythromycin in bronchiectasis subjects with frequent infective exacerbations","volume":"105","author":"Serisier","year":"2011","journal-title":"Respir Med"},{"issue":"1","key":"10.1016\/j.ccm.2012.02.001_bib43","first-page":"72","volume":"29","author":"Mikami","year":"1991","journal-title":"Nihon Kyobu Shikkan Gakkai Zasshi"},{"issue":"6","key":"10.1016\/j.ccm.2012.02.001_bib44","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1159\/000050582","article-title":"The effect of erythromycin on mucociliary transportability and rheology of cystic fibrosis and bronchiectasis sputum","volume":"68","author":"Shibuya","year":"2001","journal-title":"Respiration"},{"issue":"4","key":"10.1016\/j.ccm.2012.02.001_bib45","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1165\/ajrcmb.25.4.4552","article-title":"Inhibition of human neutrophil elastase by erythromycin and flurythromcyin, two macrolide antibiotics","volume":"25","author":"Gorrini","year":"2001","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"5","key":"10.1016\/j.ccm.2012.02.001_bib46","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1183\/09031936.97.10050994","article-title":"Effect of roxithromycin on airway responsiveness in children with bronchiectasis: a double-blind, placebo-controlled study","volume":"10","author":"Koh","year":"1997","journal-title":"Eur Respir J"},{"issue":"6","key":"10.1016\/j.ccm.2012.02.001_bib47","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1183\/09031936.99.13613809","article-title":"Clinical and immunoregulatory effects of roxithromycin therapy for chronic respiratory tract infection","volume":"13","author":"Nakamura","year":"1999","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ccm.2012.02.001_bib48","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1365-2710.2006.00708.x","article-title":"Effects of clarithromycin on inflammatory parameters and clinical conditions in children with bronchiectasis","volume":"31","author":"Yalcin","year":"2006","journal-title":"J\u00a0Clin Pharm Ther"},{"issue":"4","key":"10.1016\/j.ccm.2012.02.001_bib49","first-page":"205","article-title":"Bronchiectasis and macrolides","volume":"42","author":"Vila-Justribo","year":"2006","journal-title":"Arch Bronconeumol"},{"issue":"2","key":"10.1016\/j.ccm.2012.02.001_bib50","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1093\/jac\/33.2.289","article-title":"The concentrations of clarithromycin and its 14-hydroxy metabolite in sputum of patients with bronchiectasis following single dose oral administration","volume":"33","author":"Tsang","year":"1994","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"1","key":"10.1016\/j.ccm.2012.02.001_bib51","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1378\/chest.122.1.213","article-title":"Effect of a short course of clarithromycin therapy on sputum production in patients with chronic airway hypersecretion","volume":"122","author":"Tagaya","year":"2002","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.ccm.2012.02.001_bib52","doi-asserted-by":"crossref","first-page":"138","DOI":"10.11150\/kansenshogakuzasshi1970.68.138","article-title":"Bacterial biofilm in chronic airway infection","volume":"68","author":"Ohgaki","year":"1994","journal-title":"Kansenshogaku Zasshi"},{"key":"10.1016\/j.ccm.2012.02.001_bib53","first-page":"540","article-title":"Prophylactic antibiotic treatment of bronchiectasis with azithromycin","volume":"59","author":"Davies","year":"2004","journal-title":"Thorax"},{"issue":"2","key":"10.1016\/j.ccm.2012.02.001_bib54","doi-asserted-by":"crossref","first-page":"117","DOI":"10.2165\/00151829-200504020-00005","article-title":"The disease-modifying effects of twice-weekly oral azithromycin in patients with bronchiectasis","volume":"4","author":"Cymbala","year":"2005","journal-title":"Treat Respir Med"},{"key":"10.1016\/j.ccm.2012.02.001_bib55","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1016\/j.rmed.2008.06.005","article-title":"Effects of long-term low-dose azithromycin in patients with non-CF bronchiectasis","volume":"102","author":"Anwar","year":"2008","journal-title":"Respir Med"},{"issue":"5","key":"10.1016\/j.ccm.2012.02.001_bib56","first-page":"1","volume":"41","author":"Carro","year":"2005","journal-title":"Arch Bronconeumol"},{"issue":"8","key":"10.1016\/j.ccm.2012.02.001_bib57","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/j.healun.2004.06.025","article-title":"Effect of azithromycin on bronchiectasis and pulmonary function in a heart-lung transplant patient with severe chronic allograft dysfunction: a case report","volume":"24","author":"Verleden","year":"2005","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.ccm.2012.02.001_bib58","article-title":"Leukotriene receptor antagonists for non-cystic fibrosis bronchiectasis","volume":"4","author":"Corless","year":"2000","journal-title":"Cochrane Database Syst Rev"},{"issue":"9","key":"10.1016\/j.ccm.2012.02.001_bib59","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1183\/09031936.95.08091479","article-title":"In\u00a0vivo study of indomethacin in bronchiectasis: effect on neutrophil function and lung secretion","volume":"8","author":"Llewellyn-Jones","year":"1995","journal-title":"Eur Respir J"},{"issue":"3","key":"10.1016\/j.ccm.2012.02.001_bib60","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1164\/ajrccm\/145.3.548","article-title":"Effect of indomethacin on bronchorrhea in patients with chronic bronchitis, diffuse panbronchiolitis, or bronchiectasis","volume":"145","author":"Tamaoki","year":"1992","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.ccm.2012.02.001_bib61","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD007525.pub2","article-title":"Inhaled non-steroid anti-inflammatories for children and adults with bronchiectasis","volume":"4","author":"Pizzutto","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"10.1016\/j.ccm.2012.02.001_bib62","first-page":"177","article-title":"Effect of cyclooxygenase inhibitor on excessive sputum","volume":"82","author":"Inoue","year":"1991","journal-title":"Fukuoka Igaku Zasshi"},{"key":"10.1016\/j.ccm.2012.02.001_bib63","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD006427","article-title":"Oral non steroid anti-inflammatories for children and adults with bronchiectasis","volume":"4","author":"Kapur","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ccm.2012.02.001_bib64","article-title":"Oral methyl-xanthines for bronchiectasis","volume":"1","author":"Steele","year":"2001","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ccm.2012.02.001_bib65","article-title":"Long-acting beta-2-agonists for bronchiectasis","volume":"4","author":"Sheikh","year":"2001","journal-title":"Cochrane Database Syst Rev"}],"container-title":["Clinics in Chest Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272523112000251?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272523112000251?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T00:48:04Z","timestamp":1759452484000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272523112000251"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6]]},"references-count":65,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["S0272523112000251"],"URL":"https:\/\/doi.org\/10.1016\/j.ccm.2012.02.001","relation":{},"ISSN":["0272-5231"],"issn-type":[{"value":"0272-5231","type":"print"}],"subject":[],"published":{"date-parts":[[2012,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Use of Antiinflammatory Therapy and Macrolides in Bronchiectasis","name":"articletitle","label":"Article Title"},{"value":"Clinics in Chest Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ccm.2012.02.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}